Fidelity Investments
PMVP icon

Fidelity Investments’s PMV Pharmaceuticals PMVP Stock Holding History

Fidelity Investments’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-315
Closed -$343 – 5457
2025
Q1 		$343 Sell
315
-690
-69% -$937 ﹤0.01% 5051
2024
Q4 		$1.52K Hold
1,005
– – ﹤0.01% 4865
2024
Q3 		$1.5K Sell
1,005
-2,587
-72% -$4K ﹤0.01% 4858
2024
Q2 		$5.82K Buy
3,592
+1,065
+42% +$1.92K ﹤0.01% 4504
2024
Q1 		$4.3K Buy
2,527
+211
+9% +$394 ﹤0.01% 4549
2023
Q4 		$7.18K Sell
2,316
-749
-24% -$1.98K ﹤0.01% 4343
2023
Q3 		$18.8K Buy
3,065
+356
+13% +$2.45K ﹤0.01% 3840
2023
Q2 		$17K Buy
2,709
+444
+20% +$2.33K ﹤0.01% 3938
2023
Q1 		$10.8K Buy
2,265
+1,486
+191% +$10.5K ﹤0.01% 4095
2022
Q4 		$6.78K Sell
779
-772,317
-100% -$8.23M ﹤0.01% 4151
2022
Q3 		$9.2M Buy
773,096
+45
+0% +$650 ﹤0.01% 1927
2022
Q2 		$11M Buy
773,051
+326,932
+73% +$4.76M ﹤0.01% 1934
2022
Q1 		$9.29M Sell
446,119
-56,581
-11% -$998K ﹤0.01% 2148
2021
Q4 		$11.6M Sell
502,700
-151,700
-23% -$3.67M ﹤0.01% 2056
2021
Q3 		$19.5M Buy
654,400
+123,686
+23% +$3.95M ﹤0.01% 1857
2021
Q2 		$18.1M Buy
530,714
+109,314
+26% +$3.65M ﹤0.01% 1881
2021
Q1 		$13.9M Sell
421,400
-800
-0.2% -$31.5K ﹤0.01% 1928
2020
Q4 		$26M Buy
422,200
+11,000
+3% +$432K ﹤0.01% 1597
2020
Q3 		$14.6M Buy
+411,200
New +$15.1M ﹤0.01% 1700

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Fidelity Investments's PMVP Position: Q2 2025 in Review

Fidelity Investments sold out of PMV Pharmaceuticals (PMVP) in Q2 2025, closing a stake of 315 shares — an estimated $343 sold.

Fidelity Investments first reported a position in PMVP in Q3 2020 and held it in 19 quarters. The position peaked at $26M in Q4 2020. 54 funds tracked by Wall St. Rank hold PMVP as of Q2 2025.

  • Fidelity Investments reported no remaining PMV Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 315 PMV Pharmaceuticals shares in Q2 2025, an estimated $343.
  • Fidelity Investments first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 19 quarters.
  • Fidelity Investments's PMV Pharmaceuticals position peaked at $26M in Q4 2020.
  • 54 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.